Above Food Ingredients Inc. (ABVE) 株式分析

企業概要

Above Food Ingredients Inc. operates as a regenerative ingredient company that produces vertically integrated supply chain products across Canada, the United States, Mexico, China, France, Turkey, and international markets. The company functions within the Consumer Defensive sector, specifically under the Packaged Foods industry, a classification that typically denotes businesses providing essential goods with relatively stable demand regardless of economic cycles. With a market capitalization of $40.21M and annual revenue of $294.84M, the firm maintains a small-cap profile that suggests it is a specialized player rather than a dominant market leader. The absence of publicly disclosed employee count data further limits the immediate assessment of its operational scale, though the revenue figures indicate a significant top-line operation that generates nearly $300 million in annual sales. These valuation metrics imply that the market currently values the entity at a very low multiple of its sales, reflecting a niche position within the broader food ingredients landscape.

財務健全性

The company reported revenue of $294.84M for the trailing twelve months, yet it recorded a net income of $-61,292,864 and an EBITDA of $-40,343,004, revealing a substantial disconnect between top-line generation and profitability. This wide gap between revenue and net income highlights a highly aggressive or inefficient cost structure where operating expenses and taxes significantly erode the bottom line despite substantial sales volume. While free cash flow data is not available, the negative EBITDA and net income suggest that the company is currently consuming cash rather than generating it, which severely constrains its financial flexibility and ability to fund operations without external financing. The gross margin stands at -2.8%, indicating that the cost of goods sold exceeds the revenue generated per unit, a critical sign of structural pricing issues or high production costs. Furthermore, the operating margin of -23.3% and profit margin of -23.4% demonstrate that operational inefficiencies and tax burdens are deeply impacting the company's ability to convert sales into operating cash. On the balance sheet, the company holds $664,430 in cash against $133.84M in debt, resulting in a debt-to-equity ratio that is not disclosed but implies a highly leveraged position given the negative equity. The current ratio of 0.23 indicates a severe short-term liquidity crisis, as current liabilities significantly exceed current assets, suggesting the company may struggle to meet its obligations due within one year. Return on Equity and Return on Assets are not available due to the negative equity position, but the implied returns are negative, reflecting management's current inability to generate value from shareholder capital or the company's total asset base.

バリュエーション評価

Trailing and forward P/E ratios are not available due to the company's lack of profitability, meaning traditional earnings-based valuation multiples cannot be applied to assess its current stock price. The price-to-book ratio is -1.83, a negative figure that indicates the market is valuing the company at a fraction of its book value, often seen in distressed assets or entities with significant liabilities exceeding assets. The price-to-sales ratio of 0.14 and an EV/EBITDA of -3.86 provide alternative perspectives, showing that investors are pricing the stock at roughly 14% of its annual sales, which is a very low multiple typically associated with high-risk or turnaround situations. The stock has traded between a 52-week high of $6.56 and a low of $0.32, with the current price implied by the valuation metrics to be trading in a range that reflects significant volatility and downside risk relative to the 52-week high. The beta of 0.13 suggests that the stock's price volatility is significantly lower than the broader market, moving only about 13% as much as the S&P 500, which is unusual for a company with such negative financial fundamentals. This low beta indicates that the stock does not move in tandem with general market trends, behaving more as an idiosyncratic asset driven by specific company events rather than macroeconomic factors.

Growth & Income

Revenue growth year-over-year is -45.0%, while earnings growth is not applicable due to the negative net income, indicating that the company is contracting rapidly rather than expanding its market share or sales base. The absence of positive earnings growth relative to revenue suggests that the decline in sales is exacerbating the company's existing profitability issues, leading to a compounding effect on losses. As a non-dividend payer, the company has a dividend yield of N/A and a payout ratio of 0.0%, meaning it distributes no cash to shareholders and instead retains earnings, though in this case, those retained earnings are negative. Consequently, the company is not reinvesting positive earnings into growth but is instead burning through cash reserves to cover operational deficits. The overall growth and income profile is characterized by significant revenue contraction, negative profitability, and a complete lack of dividend income, presenting a challenging financial trajectory for any investor holding the position.